Pharmacogenetics-based population pharmacokinetic analysis and dose optimization of valproic acid in Chinese southern children with epilepsy: Effect of ABCB1 gene polymorphism
Objective: The aim of this study was to establish a population pharmacokinetic (PPK) model of valproic acid (VPA) in pediatric patients with epilepsy in southern China, and provide guidance for individualized medication of VPA therapy.Methods: A total of 376 VPA steady-state trough concentrations we...
Main Authors: | Xianhuan Shen, Xinyi Chen, Jieluan Lu, Qing Chen, Wenzhou Li, Jiahao Zhu, Yaodong He, Huijuan Guo, Chenshu Xu, Xiaomei Fan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.1037239/full |
Similar Items
-
Association of ABCB1 Polymorphisms with Efficacy and Adverse Drug Reactions of Valproic Acid in Children with Epilepsy
by: Jiahao Zhu, et al.
Published: (2023-10-01) -
Population Pharmacokinetics of Valproic Acid in Epileptic Patients at Prasat Neurological Institute
by: Weenarat Senawin, et al.
Published: (2014-08-01) -
Population Pharmacokinetics of Valproic Acid in Pediatric and Adult Caucasian Patients
by: Paulo Teixeira-da-Silva, et al.
Published: (2022-04-01) -
AS3MT Polymorphism: A Risk Factor for Epilepsy Susceptibility and Adverse Drug Reactions to Valproic Acid and Oxcarbazepine Treatment in Children From South China
by: Xiaomei Fan, et al.
Published: (2021-11-01) -
Platelet counts in epileptic children receiving valproic acid
by: Lilik Indrayati, et al.
Published: (2020-01-01)